[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys

Synapse

Volumn 27, Issue 3, 1997, Pages 183-190

  Booij, Jan ^a   Andringa, Gerda ^b   Rijks, Leonie J M ^a   Vermeulen, R Jeroen ^c   De Bruin, Kora ^a   Boer, Gerard J ^a,c   Janssen, Anton G M ^d   Van Royen, Eric A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

123I FP CIT; Cocaine analogues; Dopamine transporter imaging; MPTP; SPECT

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; FLUVOXAMINE; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)TROPANE; RADIOLIGAND; SEROTONIN; UNCLASSIFIED DRUG; VANOXERINE; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; CARRIER PROTEIN; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC IMAGING; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG UPTAKE; MALE; MONKEY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BINDING COMPETITION; BRAIN; DRUG EFFECT; INTOXICATION; METABOLISM; NEOSTRIATUM; RADIOASSAY; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CARRIER PROTEINS; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MPTP POISONING; NEOSTRIATUM; NERVE TISSUE PROTEINS; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0030610535     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3.0.CO;2-9     Document Type: Article

References (44)

1. Abi-Dargham, A., Gandelman, M.S., DeErausquin, G.A., Zea-Ponce, Y., Zoghi, S.S., Baldwin, R.M., Laruelle, M., Charney, D.S., Hoffer, P.B., Neumeyer, J.L., and Innis, R.B. (1996) SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J. Nucl. Med., 37:1129-1133.
2. Andersen, P.H. (1989) The dopamine uptake inhibitor GBR12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol., 166:493-504.
3. 123I]N-ω-fluoroalkyl-2β-carboxy-3β-(4-iodophenyl) nortropane esters in baboons. Nucl. Med. Biol., 22:211-219.
4. Bankiewicz, K.S., Oldfield, E.H., Chiueh, C.C., Doppman, J.L., Jacobowitz, D.M., and Kopin, I.J. (1986) Hemiparkinsonism in monkeys after unilateral internal carotid infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci., 39:7-16.
5. 123I]β-CIT in human plasma may obstruct quantitation of the dopamine transporter. Synapse, 19:297-300.
6. Boja, J.W., Kuhar, M.J., Kopajtic, T., Yang, E., Abraham, P., Lewin, A.H., and Carroll, F.I. (1994) Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J. Med. Chem., 37:1220-1223.
7. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 62:133-140.
8. 123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur. J. Nucl. Med., 24:68-71.
9. 123I]β-CIT. Binding kinetics in the human brain. J. Neural. Transm. Gen. Sect., 94:137-146.
10. Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J. (1983) A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U. S. A., 80:4546-4550.
11. Claassen, V., Davies, J.E., Hertting, G., and Placheta, P. (1977) Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br. J. Pharmacol., 60:505-516.
12. Elsworth, J.D., Brittan, M.S., Taylor, J.R., Sladek, J.R., Al-Tikriti, M.S., Zea-Ponce, Y., Innis, R.B., Redmond, D.E., and Roth, R.H. (1996) Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, hut not sham-grafted, MPTP-treated parkinsonian monkeys. Cell Transpl., 5:315-325.
13. Foulon, C., Garreau, L., Chalon, S., Desplanches, G., Frangin, Y., Besnard, J.-C., Baulieu, J.L., and Guilloteau, D. (1992) Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands. Nucl. Med. Biol., 19:597-600.
14. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol., 34:423-431.
15. Gnanalingham, K.K., Milkowski, N.A., Smith, L.A., Hunter, A.J., Jenner, P., and Marsden, C.D. (1995) Short-and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Eur. J. Pharmacol., 277:235-241.
16. 3H. In: Abstracts XIst International Symposium on Radiopharmaceutical Chemistry, Vancouver, Canada. Elsevier, New York, pp. 49-51.
17. Hansen, J.T., Sakai, K., Greenamyre, J.T., and Moran, S. (1995) Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res., 670:197-204.
18. 123I-labelled derivative of GBR12783, a potential agent for SPECT imaging of dopamine-reuptake sites. J. Lab. Comp. Radiopharm., 33:493-500.
19. Innis, R.B., Seibyl, J.B., Scanley, B.E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R.M., Zea-Ponce, Y., Wang, S., Gao, Y., Neumeyer, J.L., Charney, D.S., Hoffer, P.B., and Marek, K.L. (1993) Single photon computed imaging demonstrated loss of striatal dopamine transporters in Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A., 90:11965-11969.
20. Ishikawa, T., Dhawan, V., Kazumata, K., Chaly, T., Mandel, F., Neumeyer, J., Margouleff, C., Babchyck, B., Zanzi, I., and Eidelberg, D. (1996) Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J. Nucl. Med., 37:1760-1765.
21. 18F]GBR 13119. Imaging the dopamine uptake system in vivo. Nucl. Med. Biol., 16:569-576.
22. Koeppe, R.A., Kilbourn, M.R., Frey, K.A., Penney, J.B., Haka, M.S., and Kuhl, D.E. (1990) Imaging and kinetic modeling of [F-18]GBR12909, a dopamine uptake inhibitor. J. Nucl. Med. Abstr., 31:720.
23. Kuhar, M.J., Aghajanian, G.K., and Roth, R.H. (1972) Trytophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: Correlations with serotonin levels and histochemical fluorescence. Brain Res., 44:165-176.
24. Kuikka, J.T., Bergström, K.A., Ahonen, A., Hiltunen, J., Haukka, J., Länsimies, E., Wang, S., and Neumeyer, J.L. (1995) Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur. J. Nucl. Med., 22:356-360.
25. 123I] β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse, 13:295-309.
26. Leenders, K.L., Aquilonius, S.-M., Bergström, K., Bjurling, P., Crossman, A.R., Eckernas, S.-Å., Gee, A.G., Hartvig, P., Lundqvist, H., Långström, B., Rimland, A., and Tedroff, J. (1988) Unilateral MPTP lesion in a rhesus monkey: Effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res., 445:61-67.
27. Leenders, K.L., Salmon, E.P., Tyrrell, P., Perani, D., Brooks, D.J., Sager, H., Jones, T., Marsden, C.D., and Frackowiak, R.S.J. (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol., 47:1290-1298.
28. 11C]β-CIT-FP, a potential radioligand for the dopamine transporter: Preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl. Med. Biol., 22:905-913.
29. Lundkvist, C., Halldin, C., Swahn, C.-G., Müller, L., Ginovart, N., Nakashima, Y., Karlsson, P., Neumeyer, J.L., Wang, S., Milius, R.A., and Farde, L. (1995b) Synthesis of 11C-or 18F-labelled analogues of β-CIT. Labelling in different positions and PET evaluations in cynomolgus monkeys. In: Abstracts XIst International Symposium on Radiopharmaceutical Chemistry, Vancouver, Canada. Elsevier, New York, pp. 52-54.
30. Müller, L., Halldin, C., Foged, C., Karlsson, P., Hall, H., Swahn, C.-G., Sudzak, P.D., Hohlweg, R., Nielsen, E.B., and Farde, L. (1994) Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. Eur. J. Nucl. Med., 21:131-137.
31. Neumeyer, J.L., Wang, S., Gao, Y., Milius, R.A., Kula, N.S., Campbell, A., Baldessarini, R.J., Zea-Ponce, Y., Baldwin, R.M., and Innis, R.B. (1994) N-ω-fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl)-tropane(β-CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of the dopamine transporter. J. Med. Chem., 37:1558-1561.
32. Neumeyer, J.L., Tamagnan, G., Wang, S., Gao, Y., Milius, R.A., Kula, N.S., and Baldessarini, R.J. (1996) N-substituted analogs of 2β-carbomethoxy-3β-(4′-iodophenyl)tropane(β-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J. Med. Chem., 39:543-548.
33. Pifl, Ch., Schingnitz, G., and Hornykiewicz, O. (1991) Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience, 44:591-605.
34. Rijks, L.J.M., Booij, J., Doornbos, T., Boer, G.J., Ronken, E., de Bruin, K., Vermeulen, R.J., Janssen, A.G.M., and van Royen, E.A. (1996) In vitro and in vivo characterization of newly developed iodinated 1-2-[bis(4-fluorophenyl)methody]ethyl piperazine derivatives in rats: Limited value as dopamine transporter SPECT ligands. Synapse, 23:201-207.
35. 11C]β-CFT in early Parkinson's disease. Synapse, 21:97-103.
36. Rose, S., Nomoto, M., Kilpatrick, G., Jenner, P., and Marsden, C.D. (1989a) Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neurosci. Lett., 101:305-310.
37. Rose, S., Nomoto, M., Jenner, P., and Marsden, C.D. (1989b) Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochem. Pharmacol., 38:3677-3681.
38. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse, 11:134-139.
39. 125I]RTI-55. Synapse, 16:63-268.
40. Shaya, E.K., Scheffel, U., Dannals, R.F., Ricaurte, G.A., Carroll, F.I., Wagner, H.N., Jr., Kuhar, M.J., and Wong, D.F. (1992) In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55. Synapse, 10:169-172.
41. 125I]RTI-55: In vitro binding and autographic characterization. J. Neurochem., 62:549-556.
42. Tedroff, T. (1990) Parkinson's Disease - Pathophysiology and PET. Thesis, Uppsala Universitet, Uppsala.
43. Van Dort, M.E., Kilbourn, M.R., Chakraborty, P.K., Richfield, E.K., Gidersleeve, D.L., and Wieland, D.M. (1992) Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: Potential radiopharmaceuticals for in vivo study of the dopamine uptake system. Appl. Radiat. Isot., 43:671-680.
44. 123I]IBZM as measured with SPECT in MPTP monkeys. Synapse, 17:115-124.